Climb Bio, Inc. (CLYM)
14.25
-0.70
(-4.68%)
USD |
NASDAQ |
Sep 11, 16:00
14.25
0.00 (0.00%)
After-Hours: 20:00
Climb Bio Market Cap : 818.47M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 818.47M |
| September 10, 2026 | 858.67M |
| September 09, 2026 | 864.42M |
| September 08, 2026 | 913.24M |
| September 04, 2026 | 891.41M |
| September 03, 2026 | 838.00M |
| September 02, 2026 | 864.42M |
| September 01, 2026 | 851.21M |
| August 31, 2026 | 788.60M |
| August 28, 2026 | 836.85M |
| August 27, 2026 | 864.99M |
| August 26, 2026 | 923.58M |
| August 25, 2026 | 1.025B |
| August 24, 2026 | 941.96M |
| August 21, 2026 | 992.50M |
| August 20, 2026 | 977.57M |
| August 19, 2026 | 995.95M |
| August 18, 2026 | 998.82M |
| August 17, 2026 | 1.002B |
| August 14, 2026 | 937.93M |
| August 13, 2026 | 846.04M |
| August 12, 2026 | 826.51M |
| August 11, 2026 | 795.49M |
| August 10, 2026 | 777.69M |
| August 07, 2026 | 804.11M |
| Date | Value |
|---|---|
| August 06, 2026 | 804.11M |
| August 05, 2026 | 716.23M |
| August 04, 2026 | 721.40M |
| August 03, 2026 | 564.15M |
| July 31, 2026 | 568.45M |
| July 30, 2026 | 577.04M |
| July 29, 2026 | 578.48M |
| July 28, 2026 | 587.07M |
| July 27, 2026 | 610.96M |
| July 24, 2026 | 613.35M |
| July 23, 2026 | 609.53M |
| July 22, 2026 | 600.93M |
| July 21, 2026 | 625.77M |
| July 20, 2026 | 583.73M |
| July 17, 2026 | 606.66M |
| July 16, 2026 | 600.93M |
| July 15, 2026 | 662.55M |
| July 14, 2026 | 632.45M |
| July 13, 2026 | 631.02M |
| July 10, 2026 | 668.76M |
| July 09, 2026 | 660.16M |
| July 08, 2026 | 648.22M |
| July 07, 2026 | 641.05M |
| July 06, 2026 | 633.89M |
| July 02, 2026 | 616.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Artiva Biotherapeutics, Inc. | 498.66M |
| Arrowhead Pharmaceuticals, Inc. | 11.69B |
| Oncolytics Biotech, Inc. | 92.92M |
| Sangamo Therapeutics, Inc. | 61.52M |
| Sarepta Therapeutics, Inc. | 2.160B |
Market Cap Related Metrics
| PEG Ratio | -0.8921 |
| Price to Book Value | 3.417 |
| Price | 14.25 |
| Earnings Yield | -5.81% |
| PEGY Ratio | -0.8921 |